|
2020 Other Outputs Identification and phenotype of MAIT cells in cattle and their response to bacterial infectionsEdmans, Matthew D., Connelley, Timothy K., Jayaraman, Siddharth, Vrettou, Christina, Vordermeier, Martin, Mak, Jeffrey Y. W., Liu, Ligong, Fairlie, David P., Maze, Emmanuel Atangana, Chrun, Tiphany, Klenerman, Paul, Eckle, Sidonia B. G., Tchilian, Elma and Benedictus, Lindert (2020). Identification and phenotype of MAIT cells in cattle and their response to bacterial infections. doi: 10.1101/2020.11.09.374678 |
|
2020 Other Outputs Priming programed Mucosal-Associated Invariant T cells protect against systemic or local bacterial infectionZhao, Zhe, Shi, Mai, Zhu, Tianyuan, Wang, Huimeng, Pediongco, Troi, Lim, Xin Yi, Meehan, Bronwyn, Nelson, Adam, Fairlie, David, Mak, Jeffrey, Eckle, Sidonia, Rossjohn, Jamie, McCluskey, James, Corbett, Alexandra and Chen, Zhenjun (2020). Priming programed Mucosal-Associated Invariant T cells protect against systemic or local bacterial infection. doi: 10.21203/rs.3.rs-39302/v1 |
|
2019 Other Outputs Supplementary Data tables for: Orally absorbed cyclic peptidesNielsen, Daniel S., Shepherd, Nicholas E., Xu, Weijun, Lucke, Andrew J., Stoermer, Martin J. and Fairlie, David P. (2019). Supplementary Data tables for: Orally absorbed cyclic peptides. The University of Queensland. (Dataset) doi: 10.14264/uql.2019.213 |
|
2019 Other Outputs Supplementary Figure S1Iyer, Abishek, Humphries, Tyrone LR, Owens, Evan P, Zhao, Kong-Nan, Masci, Paul P, Gobe, Glenda C, Johnson, David W, Paterson, David Nikolic, Fairlie, David P and Vesey, David A (2019). Supplementary Figure S1. The University of Queensland. (Dataset) doi: 10.14264/uql.2019.810 |
|
2015 Other Outputs Reactivity of commercially available Fmoc amino acids: supplementary informationLindahl, Fredrik, Hoang, Huy Ngoc, Fairlie, David P. and Cooper, Matthew A. (2015). Reactivity of commercially available Fmoc amino acids: supplementary information. The Royal Society of Chemistry. (Dataset) |
|
2007 Other Outputs Compounds and inhibitors of phospholipasesReid, Robert C., Clark, Christopher I., Hansford, Karl, Stoermer, Martin J., McGeary, Ross P., Fairlie, David P. and Schafer, Karl (2007). Compounds and inhibitors of phospholipases. US7253194. |
|
2007 Other Outputs New amino acid derivatives useful for the treatment of inflammatory disease or condition e.g. rheumatic arthritisClark, C. I., Fairlie, D. P., Hansford, K., McGeary, R. P., Reid, R. C. and Stoermer, M. J. (2007). New amino acid derivatives useful for the treatment of inflammatory disease or condition e.g. rheumatic arthritis. |
|
2004 Other Outputs Compounds and inhibitors of phospholipasesReid, Robert C., Clark, Christopher I., Hansford, Karl, Stoermer, Martin J., McGeary, Ross P., Fairlie, David P. and Schafer, Karl (2004). Compounds and inhibitors of phospholipases. US2004033995. |
|
2003 Other Outputs New cyclic peptide or peptidomimetic compounds, are G-protein coupled receptor antagonists useful for treating inflammatory disorders such as rheumatoid arthritis, reperfusion injury or dermal inflammationTaylor, Steve, Shiels, Ian Alexander and Fairlie, David (2003). New cyclic peptide or peptidomimetic compounds, are G-protein coupled receptor antagonists useful for treating inflammatory disorders such as rheumatoid arthritis, reperfusion injury or dermal inflammation. WO/2003/033528. |
|
2002 Other Outputs Compounds and inhibitors of phospholipasesReid, Robert C., Clark, Christopher I., Hansford, Karl, Stoermer, Martin J., McGeary, Ross P. and Fairlie, David P. (2002). Compounds and inhibitors of phospholipases. WO0208189. |
|
1999 Other Outputs Cyclic agonists and antagonists of c5a receptors and g protein-coupled receptorsFairlie, David, Taylor, Stephen Maxwell, Finch, Angela Monique and Wong, Allan (1999). Cyclic agonists and antagonists of c5a receptors and g protein-coupled receptors. WO/1999/000406. |
